Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor

J Liu, BH Bodnar, F Meng, AI Khan, X Wang, S Saribas… - Cell & bioscience, 2021 - Springer
Background As the COVID-19 pandemic rages on, the new SARS-CoV-2 variants have
emerged in the different regions of the world. These newly emerged variants have mutations …

The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection

L Henss, A Auste, C Schürmann… - Journal of General …, 2021 - microbiologyresearch.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has caused a
pandemic with tens of millions of cases and more than a million deaths. The infection causes …

Therapeutic potential of EGCG, a green tea polyphenol, for treatment of coronavirus diseases

J Park, R Park, M Jang, YI Park - Life, 2021 - mdpi.com
Epigallocatechin gallate (EGCG) is a major catechin found in green tea, and there is
mounting evidence that EGCG is potentially useful for the treatment of coronavirus diseases …

Antiviral effects of green tea EGCG and its potential application against COVID-19

YQ Wang, QS Li, XQ Zheng, JL Lu, YR Liang - Molecules, 2021 - mdpi.com
(–)-Epigallocatechin-3-O-gallate (EGCG), the most abundant component of catechins in tea
(Camellia sinensis (L.) O. Kuntze), plays a role against viruses through inhibiting virus …

Significant inactivation of SARS-CoV-2 in vitro by a green tea catechin, a catechin-derivative, and black tea galloylated theaflavins

E Ohgitani, M Shin-Ya, M Ichitani, M Kobayashi… - Molecules, 2021 - mdpi.com
Potential effects of tea and its constituents on SARS-CoV-2 infection were assessed in vitro.
Infectivity of SARS-CoV-2 was decreased to 1/100 to undetectable levels after a treatment …

Potential protective mechanisms of green tea polyphenol EGCG against COVID-19

Z Zhang, X Zhang, K Bi, Y He, W Yan, CS Yang… - Trends in food science & …, 2021 - Elsevier
Background The world is in the midst of the COVID-19 pandemic. In this comprehensive
review, we discuss the potential protective effects of (−)-epigallocatechin-3-gallate (EGCG) …

EGCG, a green tea catechin, as a potential therapeutic agent for symptomatic and asymptomatic SARS-CoV-2 infection

M Chourasia, PR Koppula, A Battu, MM Ouseph… - Molecules, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has emerged to be the greatest threat to humanity in the …

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike …

T Ohishi, T Hishiki, MS Baig, S Rajpoot, U Saqib… - PLoS …, 2022 - journals.plos.org
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory
syndrome coronavirus 2 triggered a global pandemic where control is needed through …

Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs

A Tito, A Colantuono, L Pirone, E Pedone… - Frontiers in …, 2021 - frontiersin.org
Plant extracts are rich in bioactive compounds, such as polyphenols, sesquiterpenes, and
triterpenes, which potentially have antiviral activities. As a consequence of the coronavirus …

Epigallocatechin gallate (EGCG), a green tea polyphenol, reduces coronavirus replication in a mouse model

R Park, M Jang, YI Park, Y Park, W Jung, J Park, J Park - Viruses, 2021 - mdpi.com
The COVID-19 pandemic has resulted in a huge number of deaths from 2020 to 2021;
however, effective antiviral drugs against SARS-CoV-2 are currently under development …